August 31, 2020
More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.
The study looked at the proportion of Livongo members who had high blood pressure before and during the pandemic, specifically covering the time between mid-September of 2019 and mid-August of 2020.
The data does not support a...
November 15, 2019
Livongo is touting new data regarding the efficacy of its device-and-coaching disease management platform, this time among those using its Livongo for Hypertension and Livongo for Diabetes products together.
The results, which are set to be formally presented this weekend at the American Heart Association Scientific Sessions 2019, identified significant decreases in hypertensive blood pressure as...
April 10, 2019
A study published last month in JMIR Cardio demonstrated significant systolic and diastolic blood pressure reductions in hypertension patients who received a mobile app-based behavior change intervention.
The investigation examined Better Therapeutics’ candidate digital therapeutic for cardiovascular disease, a daily-use app that encourages users to set and record their progress toward...
March 18, 2019
At the American College of Cardiology this past weekend, chronic disease management platform Livongo reported on six-month results from its first major study of its hypertension management platform, which is already in use with many of its customers.
The study looked at 708 individuals with both diabetes and hypertension. Patients whose blood pressure was higher than 130/80 mm Hg saw their...
March 12, 2019
San Francisco-based digital chronic disease managment company Omada Health announced today that it will add fully integrated, cellular-connected glucometers and blood pressure cuffs to its offerings for Type 2 diabetes and hypertension, respectively.
The devices are FDA-cleared and can be mailed to program members. The glucometer will come with as many free test strips as users need, the company...
February 26, 2019
Yesterday Babyscripts, a virtual obstetrics care management platform, announced that it is teaming up with Penn Medicine on a new initiative designed to improve postpartum health.
The pair plan on combining Babyscripts’ remote monitoring system with the knowledge gleaned from Penn Medicine’s Heart Safe Motherhood (HSM) program, a text-based intervention for pregnancy-related hypertension.
January 31, 2019
This morning Sentinel Healthcare, a Seattle-based remote monitoring platform for patients with hypertension or other chronic diseases in need of management, announced that it has raised $2 million in new funding. The round was led by PSL Ventures.
What they do
Sentinel provides a wearable blood pressure cuffs and patient smartphone app that transmit data to the company’s wider service. This data...
January 8, 2019
Omada Health will launch new programs for customers with depression and anxiety, the company announced yesterday. The company has entered into a perpetual licensing agreement with Lantern Health, a digital mental health company that shut down its commercial operations last August, and will integrate Lantern’s software into its existing infrastructure. Additionally, a few members of Lantern’s team...
January 2, 2019
Ochsner Health System in New Orleans has been using mobile technology to monitor and manage chronic disease patients since 2015. In that time, the doctors behind the program have learned a lot about how to implement such a system, as well as about how effective it can be.
“We’ve learned a lot,” said Dr. Richard Milani, Ochsner's chief clinical transformation officer and medical director of...
July 9, 2018
WellDoc has expanded its BlueStar digital diabetes management platform to include a weight loss feature and a feature for those with both diabetes and hypertension. A standalone product for hypertension is also coming from the company later this year.
“The American Diabetes Association reports that nearly one in three American adults has hypertension, and two in three people with diabetes have...